Pages that link to "Q33845434"

The following pages link to Intravesical therapy for bladder cancer (Q33845434):

Displaying 24 items.

• Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer (Q24234614) (← links)
• Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer (Q24243739) (← links)
• Immune Cells in Cancer Therapy and Drug Delivery (Q26747061) (← links)
• Strains, Mechanism, and Perspective: Salmonella-Based Cancer Therapy (Q26748794) (← links)
• Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy (Q26798372) (← links)
• Review Article: The Role of Ras Superfamily Proteins in Bladder Cancer Progression (Q30311889) (← links)
• Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC) (Q30433431) (← links)
• Localized bladder cancer (Q34678592) (← links)
• Combined treatment of urinary bladder cancer with the use of photodynamic therapy (PDT) and subsequent BCG-therapy: a pilot study (Q35210526) (← links)
• Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA (Q35977496) (← links)
• Antisense oligonucleotides in the treatment of bladder cancer (Q36040819) (← links)
• Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL (Q36056007) (← links)
• Intravesical drug delivery: Challenges, current status, opportunities and novel strategies (Q37787341) (← links)
• Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients (Q38409089) (← links)
• Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer (Q38668376) (← links)
• Recovery of urothelial mediator release but prolonged elevations in interleukin-8 and nitric oxide secretion following mitomycin C treatment (Q38913866) (← links)
• Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice. (Q41551244) (← links)
• In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer (Q45879149) (← links)
• Blebbishields and mitotic cells exhibit robust macropinocytosis. (Q52847065) (← links)
• Consecutive quantitative cytology in bladder cancer (Q73039897) (← links)
• Differential C-erbB-2 and VEGF expression following BCG immunotherapy in superficial papillary transitional cell carcinoma of the bladder (Q78635715) (← links)
• [Cell cycle and apoptosis mechanisms implicated in intravesical chemotherapy resistances in superficial bladder cancer] (Q81625849) (← links)
• New agents for bacillus Calmette-Guérin-refractory bladder cancer (Q86507881) (← links)
• Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer (Q89113809) (← links)